https://eliquent.com/ 2026-03-26T10:02:28+00:00 https://eliquent.com/cgt-atmp-solutions/ 2026-03-31T13:14:58+00:00 https://eliquent.com/japan-newsletter-thank-you/ 2026-03-31T16:04:21+00:00 https://eliquent.com/thank-you/ 2026-02-11T09:17:32+00:00 https://eliquent.com/esg-sustainability/ 2026-01-06T15:50:07+00:00 https://eliquent.com/regulatory-resources/ 2025-12-08T17:02:44+00:00 https://eliquent.com/webinar-fda-fallout-the-future-pw/ 2025-12-08T17:03:45+00:00 https://eliquent.com/webinar-fda-fallout-the-future/ 2025-12-08T16:38:53+00:00 https://eliquent.com/ldt-resources/ 2025-12-07T03:11:32+00:00 https://eliquent.com/qmsr-resources/ 2026-02-27T13:58:09+00:00 https://eliquent.com/engage-with-eliquent-regulatory-roadmap-podcast/ 2025-12-07T03:07:35+00:00 https://eliquent.com/shifting-landscapes-navigating-the-impact-of-an-administration-change/ 2025-12-05T10:44:37+00:00 https://eliquent.com/info-sheet-qmsr-solutions/ 2025-12-05T12:20:35+00:00 https://eliquent.com/info-sheet-regulatory-writing-solutions/ 2025-10-30T12:25:50+00:00 https://eliquent.com/sub-processor-information/ 2026-01-13T14:54:31+00:00 https://eliquent.com/sms-opt-in/ 2025-10-30T12:32:57+00:00 https://eliquent.com/iq-central/ 2025-12-08T16:46:18+00:00 https://eliquent.com/iq-central-brochures/ 2025-12-05T13:45:04+00:00 https://eliquent.com/team/ 2025-12-05T13:47:01+00:00 https://eliquent.com/focus-areas/ 2026-02-28T13:31:31+00:00 https://eliquent.com/solutions/ 2026-02-28T13:31:59+00:00 https://eliquent.com/about/ 2026-01-13T09:26:58+00:00 https://eliquent.com/careers/ 2026-02-27T13:54:31+00:00 https://eliquent.com/solutions-3/ 2025-12-07T03:16:44+00:00 https://eliquent.com/privacy-policy/ 2026-01-27T16:21:29+00:00 https://eliquent.com/resource/transitioning-to-e2br3-electronic-safety-reporting-for-inds/ 2025-12-17T17:27:18+00:00 https://eliquent.com/solution/gxp-consulting-implementation/ 2026-03-09T18:09:57+00:00 https://eliquent.com/focus-area/medical-device-consulting/ 2026-03-11T02:38:53+00:00 https://eliquent.com/focus-area/cmc-regulatory-affairs/ 2026-01-15T09:59:53+00:00 https://eliquent.com/focus-area/pharmaceutical-regulatory-consulting/ 2026-01-15T09:58:23+00:00 https://eliquent.com/focus-area/pharma-compliance-consulting/ 2026-01-15T09:57:32+00:00 https://eliquent.com/resource/ich-e6-r3-a-new-era-of-inspection-readiness/ 2026-01-14T09:53:48+00:00 https://eliquent.com/resource/discriminatory-power-the-make-or-break-factor-in-dissolution-methods/ 2026-01-14T09:10:07+00:00 https://eliquent.com/resource/comments-on-the-quality-considerations-for-topical-ophthalmic-drug-products-guidance/ 2026-02-27T13:45:54+00:00 https://eliquent.com/resource/not-the-usual-suspects-fdas-drug-recalls-oral-dosage-forms-edition/ 2026-01-14T08:58:27+00:00 https://eliquent.com/resource/webinar-watch-squash-software-issues-in-your-technical-documentation-review/ 2025-12-09T09:06:53+00:00 https://eliquent.com/resource/japans-early-consideration-on-handling-of-japanese-data-for-biosimilar-comparability/ 2025-12-09T09:45:56+00:00 https://eliquent.com/resource/eliquent-outcomes-supporting-j-nda-approval-without-local-cmc-representation/ 2026-01-14T09:47:47+00:00 https://eliquent.com/resource/new-anda-prioritization-pilot-to-support-us-generic-drug-manufacturing-and-testing/ 2025-12-09T09:46:10+00:00 https://eliquent.com/resource/what-we-learned-at-the-2025-hba-annual-conference/ 2025-12-09T09:46:20+00:00 https://eliquent.com/resource/eliquent-outcomes-strategic-supply-chain-readiness-in-japan/ 2025-12-09T09:46:26+00:00 https://eliquent.com/resource/ask-eliquent-cmc-submissions/ 2026-01-13T08:43:10+00:00 https://eliquent.com/resource/eliquent-outcomes-unlocking-approval-without-local-trials/ 2026-02-28T13:33:50+00:00 https://eliquent.com/resource/info-sheet-cmc-strategy-submission-solutions/ 2026-01-14T09:54:56+00:00 https://eliquent.com/focus-area/cmc-solutions-strategy-submissions/ 2026-02-27T13:55:31+00:00 https://eliquent.com/resource/pv-podcast/ 2026-01-13T14:19:59+00:00 https://eliquent.com/resource/pmda-symposium-2025-key-takeaways-for-pediatric-drug-development/ 2025-12-09T09:11:29+00:00 https://eliquent.com/resource/leveraging-ex-us-data-for-us-development/ 2025-12-09T09:46:59+00:00 https://eliquent.com/resource/countryside-conservation-eliquent-uk-teams-volunteer-day/ 2025-12-09T09:47:09+00:00 https://eliquent.com/resource/success-story-from-crl-to-clarity-cmc-solutions/ 2026-01-13T14:18:02+00:00 https://eliquent.com/resource/expediting-drug-development-in-japan-key-pmda-initiatives/ 2025-12-09T09:47:25+00:00 https://eliquent.com/resource/capabilities-slides-cmc-solutions/ 2026-01-13T08:43:41+00:00 https://eliquent.com/focus-area/cmc-solutions/ 2026-02-27T13:56:14+00:00 https://eliquent.com/resource/info-sheet-cmc-solutions/ 2026-01-14T09:54:20+00:00 https://eliquent.com/resource/otsuka-holdings-accelerates-mid-to-long-term-strategy-in-autoimmune-diseases-with-8-development-programs/ 2025-12-09T09:53:34+00:00 https://eliquent.com/resource/immunogenicity-evaluation-of-biopharmaceuticals/ 2025-12-09T09:53:47+00:00 https://eliquent.com/resource/japans-car-t-market-set-to-nearly-double-by-2030/ 2025-12-09T09:53:55+00:00 https://eliquent.com/resource/eliquent-outcomes-japan-case-study-enabling-simultaneous-submission/ 2025-12-09T09:54:10+00:00 https://eliquent.com/resource/iq%e6%8e%a2%e6%9e%90-%e7%bb%8f%e9%aa%8c%e3%80%81%e6%9c%ba%e9%81%87%e4%b8%8e%e6%8c%91%e6%88%98%ef%bc%9a-%e8%af%b1%e5%af%bc%e5%9e%8b%e5%a4%9a%e5%8a%9f%e8%83%bd%e5%b9%b2%e7%bb%86%e8%83%9e%ef%bc%88ipsc/ 2025-12-09T09:54:20+00:00 https://eliquent.com/resource/forging-new-regulatory-pathways-at-fda-2/ 2025-12-09T09:14:12+00:00 https://eliquent.com/resource/a-little-guidance-for-improving-reviews-of-combination-products/ 2025-12-09T09:14:20+00:00 https://eliquent.com/resource/challenges-in-combination-product-regulation/ 2025-12-09T09:14:30+00:00 https://eliquent.com/resource/fda-defines-action-of-combination-products/ 2025-12-09T09:14:38+00:00 https://eliquent.com/resource/combination-products-challenges-progress/ 2025-12-09T09:14:47+00:00 https://eliquent.com/resource/developing-an-effective-regulatory-strategy/ 2025-12-09T09:14:55+00:00 https://eliquent.com/resource/chugai-seeks-first-tumor-agnostic-approval-for-alecensa/ 2025-12-09T09:54:33+00:00 https://eliquent.com/resource/cross-labeled-combination-products-a-regulatory-conundrum-awaiting-a-solution/ 2025-12-09T09:15:11+00:00 https://eliquent.com/resource/raps-honors-7-distinguished-individuals-and-an-advocacy-group-for-contributions-to-the-regulatory-profession-and-patient-health/ 2025-12-09T09:15:51+00:00 https://eliquent.com/resource/100-notable-people-in-the-medical-device-industry/ 2025-12-09T09:16:03+00:00 https://eliquent.com/resource/five-steps-to-regulatory-strategy-development-2/ 2025-12-09T09:16:11+00:00 https://eliquent.com/resource/japans-2025-honebuto-policy-whats-next-for-pharma/ 2025-12-09T09:16:20+00:00 https://eliquent.com/resource/forging-new-regulatory-pathways-at-fda/ 2025-12-09T09:16:28+00:00 https://eliquent.com/resource/5-questions-about-device-drug-combo-products/ 2025-12-09T09:16:35+00:00 https://eliquent.com/resource/navigating-the-regulatory-landscape-of-combination-products/ 2025-12-09T09:17:28+00:00 https://eliquent.com/resource/eliquent-outcomes-japan-regulatory-path-to-global-trials/ 2025-12-09T09:17:35+00:00 https://eliquent.com/resource/five-steps-to-regulatory-strategy-development/ 2025-12-09T09:17:44+00:00 https://eliquent.com/resource/japans-pharma-market-sets-new-record-in-2024/ 2025-12-09T09:17:58+00:00 https://eliquent.com/resource/facing-the-cross-labeling-conundrum/ 2025-12-09T09:18:26+00:00 https://eliquent.com/resource/key-amendments-to-the-pmd-act-strengthening-conditional-approval-and-post-market-safety/ 2025-12-09T09:18:40+00:00 https://eliquent.com/resource/multi-regional-clinical-trials-challenges-in-applying-data-to-the-us-population/ 2025-12-09T09:18:48+00:00 https://eliquent.com/resource/ivdr-resources/ 2025-12-09T09:18:56+00:00 https://eliquent.com/resource/navigating-the-final-countdown-key-deadlines-and-compliance-requirements-for-ivdr-transition/ 2025-12-09T09:19:04+00:00 https://eliquent.com/resource/strategic-expansion-shionogi-acquires-torii-and-akros-from-jt/ 2025-12-09T09:19:12+00:00 https://eliquent.com/resource/fda-requirements-for-the-approval-of-glp-1-generic-peptide-injections/ 2025-12-09T09:19:20+00:00 https://eliquent.com/resource/dr-celia-witten-former-deputy-director-of-fdas-center-for-biologics-joins-eliquent/ 2026-01-14T09:10:36+00:00 https://eliquent.com/resource/eliquent-outcomes-fda-end-of-phase-2-eop2-meeting-success-for-a-radiopharmaceutical-company/ 2025-12-09T09:19:41+00:00 https://eliquent.com/resource/eliquent-acquires-azzur-consulting/ 2025-12-09T09:19:49+00:00 https://eliquent.com/resource/japan-case-study-accelerating-global-trials/ 2026-02-28T13:33:28+00:00 https://eliquent.com/resource/japans-new-requirement-for-pediatric-drug-development-plans-in-pmda-consultations/ 2025-12-09T09:20:06+00:00 https://eliquent.com/resource/district-court-vacates-ldt-rule-whats-next/ 2025-12-09T09:20:14+00:00 https://eliquent.com/resource/capabilities-slides-radiopharmaceutical-solutions-2/ 2026-02-28T13:34:51+00:00 https://eliquent.com/resource/eliquent-acquires-truliant-consulting/ 2026-01-14T09:12:48+00:00 https://eliquent.com/resource/info-sheet-pharmacovigilance-solutions/ 2025-12-09T09:20:54+00:00 https://eliquent.com/resource/capabilities-slides-pharmacovigilance-solutions/ 2026-02-28T13:34:16+00:00 https://eliquent.com/resource/record-breaking-growth-japans-prescription-drug-market-hits-%c2%a511-5-trillion-in-2024/ 2025-12-09T09:29:41+00:00 https://eliquent.com/resource/understanding-the-new-u-k-mhra-draft-guideline-on-individualized-mrna-cancer-immunotherapies/ 2025-12-09T09:59:39+00:00 https://eliquent.com/resource/info-sheet-radiopharmaceutical-solutions/ 2026-01-14T09:02:56+00:00 https://eliquent.com/focus-area/radiopharmaceuticals/ 2025-12-23T13:30:44+00:00 https://eliquent.com/resource/2024-new-drug-approvals-in-japan-company-rankings-and-trends/ 2025-12-09T09:30:20+00:00 https://eliquent.com/resource/eliquent-complete-capabilities/ 2026-01-14T09:47:07+00:00 https://eliquent.com/resource/info-sheet-regulatory-policy/ 2026-03-13T12:32:36+00:00 https://eliquent.com/resource/2024-top-selling-pharmaceuticals-in-japan-eliquent-japan/ 2025-12-09T09:31:01+00:00 https://eliquent.com/resource/control-of-nitrosamine-impurities-in-human-drugs/ 2025-12-09T09:31:10+00:00 https://eliquent.com/resource/one-year-to-go-fdas-new-quality-management-system-regulation-qmsr-is-getting-closer/ 2026-01-14T08:57:33+00:00 https://eliquent.com/resource/rob-wojciechowski-named-chief-operations-officer-coo/ 2025-12-09T09:31:29+00:00 https://eliquent.com/resource/regulatory-reset-the-impact-of-an-administration-change-on-fda-life-sciences-industry/ 2025-12-09T09:31:38+00:00 https://eliquent.com/resource/japans-upcoming-amendments-to-the-pharmaceutical-and-medical-device-act/ 2025-12-09T09:31:49+00:00 https://eliquent.com/focus-area/regulatory-writing-solutions/ 2025-12-23T13:30:44+00:00 https://eliquent.com/focus-area/qmsr-solutions/ 2025-12-23T13:38:45+00:00 https://eliquent.com/resource/wendy-sanhai-ph-d-mba-joins-eliquent-board-of-directors/ 2025-12-09T09:31:57+00:00 https://eliquent.com/resource/brian-mayhew-joins-firm-headlines-eliquents-expanded-regulatory-policy-service-offerings/ 2025-12-09T09:32:14+00:00 https://eliquent.com/focus-area/regulatory-policy-solutions/ 2026-03-10T14:29:50+00:00 https://eliquent.com/resource/info-sheet-full-service-support/ 2026-01-14T09:59:00+00:00 https://eliquent.com/resource/info-sheet-cosmetics-solutions/ 2026-03-05T18:51:47+00:00 https://eliquent.com/resource/info-sheet-japan-regulatory-solutions/ 2026-01-14T09:59:55+00:00 https://eliquent.com/resource/info-sheet-due-diligence-solutions/ 2026-03-13T15:50:31+00:00 https://eliquent.com/resource/info-sheet-ldt-solutions/ 2025-12-09T09:32:41+00:00 https://eliquent.com/resource/info-sheet-qmsr-solutions/ 2025-12-09T10:03:41+00:00 https://eliquent.com/resource/info-sheet-combination-product-solutions/ 2026-01-14T09:55:33+00:00 https://eliquent.com/resource/info-sheet-drugs-biologics/ 2026-03-13T11:28:13+00:00 https://eliquent.com/resource/info-sheet-medical-device-solutions/ 2026-03-31T20:22:43+00:00 https://eliquent.com/resource/info-sheet-quality-compliance-solutions/ 2026-03-10T14:31:20+00:00 https://eliquent.com/resource/info-sheet-regulatory-affairs-solutions/ 2026-03-11T14:37:12+00:00 https://eliquent.com/resource/mark-kramer-explores-single-vs-separate-combo-product-submissions/ 2025-12-09T09:36:59+00:00 https://eliquent.com/resource/info-sheet-regulatory-medical-writing/ 2026-03-13T11:39:33+00:00 https://eliquent.com/resource/shelley-gandhi-joins-eliquent/ 2025-12-09T09:38:05+00:00 https://eliquent.com/team/tim-dietlin/ 2025-12-05T15:10:21+00:00 https://eliquent.com/resource/fda-qsr-vs-qmsr-manufacturers-insights/ 2026-02-28T13:29:00+00:00 https://eliquent.com/resource/ldt-regulations-roadmap/ 2025-12-09T09:38:24+00:00 https://eliquent.com/resource/eliquent-rd-impact-drug-development/ 2025-12-09T09:38:33+00:00 https://eliquent.com/resource/3978/ 2025-12-09T10:03:18+00:00 https://eliquent.com/resource/eliquent-outcomes-japan-biopharmaceutical-indication/ 2025-12-09T09:38:49+00:00 https://eliquent.com/solution/remediation-solutions/ 2025-12-07T03:16:05+00:00 https://eliquent.com/focus-area/expert-training/ 2025-12-23T13:38:35+00:00 https://eliquent.com/focus-area/combination-products/ 2025-12-23T13:31:17+00:00 https://eliquent.com/focus-area/laboratory-developed-tests-ldts/ 2026-04-02T14:00:30+00:00 https://eliquent.com/focus-area/japan-regulatory-solutions/ 2025-12-23T13:17:31+00:00 https://eliquent.com/solution/talent-solutions/ 2026-01-29T21:58:56+00:00 https://eliquent.com/solution/pharmacovigilance/ 2025-12-07T03:20:29+00:00 https://eliquent.com/solution/regulatory-affairs/ 2026-04-01T15:45:47+00:00 https://eliquent.com/solution/quality-compliance/ 2026-04-02T12:25:56+00:00 https://eliquent.com/resource/eliquent-outcomes-private-equity-excipient/ 2026-02-28T13:29:54+00:00 https://eliquent.com/resource/eliquent-outcomes-sell-side-vaccine/ 2026-02-28T13:29:18+00:00 https://eliquent.com/resource/eliquent-outcomes-global-medical-device-firm-acquisition/ 2026-02-28T13:28:35+00:00 https://eliquent.com/resource/best-practices-for-meeting-management-under-pdufa-vii/ 2025-12-09T09:39:22+00:00 https://eliquent.com/resource/container-closure-system-component-changes/ 2026-02-28T13:29:35+00:00 https://eliquent.com/resource/fda-updates-and-re-releases-the-biosimilar-action-plan/ 2025-12-09T10:03:32+00:00 https://eliquent.com/resource/clinical-considerations-in-the-development-of-adcs/ 2025-12-09T09:40:10+00:00 https://eliquent.com/focus-area/drugs-biologics/ 2025-12-23T13:20:18+00:00 https://eliquent.com/focus-area/med-device/ 2026-04-01T17:54:49+00:00 https://eliquent.com/resource/new-post-iq-central-case-study-detail/ 2026-01-14T09:00:06+00:00 https://eliquent.com/focus-area/due-diligence/ 2025-12-23T13:01:04+00:00 https://eliquent.com/validant-group-of-companies-unite-as-eliquent-life-sciences/ 2025-10-30T15:42:06+00:00 https://eliquent.com/resource/eliquent-experts-product-quality-patient-safety/ 2025-12-09T09:40:25+00:00 https://eliquent.com/resource/dose-determination-for-radiopharmaceuticals/ 2025-12-09T09:40:33+00:00 https://eliquent.com/resource/insights-pig-heart-xenotransplantation/ 2025-12-09T09:40:40+00:00 https://eliquent.com/hello-world/ 2023-10-12T17:00:46+00:00 https://eliquent.com/resource/tim-dietlin-joins-the-company-as-ceo/ 2025-12-09T09:40:47+00:00 https://eliquent.com/team/rob-wojciechowski/ 2026-01-20T16:40:27+00:00 https://eliquent.com/team/martyn-edney-2/ 2024-11-03T19:29:40+00:00 https://eliquent.com/team/steve-purtell-2/ 2025-12-05T15:45:05+00:00 https://eliquent.com/team/nathaniel-d-cartagena/ 2025-12-05T15:42:51+00:00 https://eliquent.com/team/allison-kerska/ 2025-12-06T10:20:49+00:00 https://eliquent.com/team/john-taylor/ 2025-12-05T15:44:23+00:00 https://eliquent.com/team/jamie-portnoff/ 2025-12-06T10:20:13+00:00 https://eliquent.com/team/jennifer-harakal/ 2026-01-13T14:03:01+00:00 https://eliquent.com/team/ivan-fisher/ 2026-03-30T14:43:04+00:00 https://eliquent.com/team/heather-johnson/ 2025-12-22T22:06:35+00:00 https://eliquent.com/team/kathleen-sonntag-2/ 2025-12-05T15:42:13+00:00 https://eliquent.com/team/ifty-saiyed/ 2025-12-05T15:41:43+00:00 https://eliquent.com/team/shunsuke-iwano-ph-d/ 2026-01-13T13:49:48+00:00 https://eliquent.com/team/shelley-gandhi/ 2026-01-13T13:53:30+00:00 https://eliquent.com/team/helm-siegel/ 2026-01-13T14:07:50+00:00 https://eliquent.com/team/theodore-ted-hellen/ 2025-12-06T11:02:37+00:00 https://eliquent.com/team/katherine-mueller/ 2025-12-05T15:54:44+00:00 https://eliquent.com/team/david-candito/ 2025-12-05T15:44:49+00:00 https://eliquent.com/team/sandra-kweder-m-d/ 2025-12-05T15:12:48+00:00 https://eliquent.com/team/david-elder-2/ 2026-01-21T19:44:52+00:00 https://eliquent.com/team/celia-witten/ 2025-12-06T10:30:45+00:00 https://eliquent.com/team/heather-s-rosecrans-f-r-a-p-s/ 2025-12-05T15:41:59+00:00 https://eliquent.com/team/donald-d-ashley-jd/ 2026-01-13T14:14:34+00:00 https://eliquent.com/team/brian-mayhew/ 2025-12-05T15:52:54+00:00 https://eliquent.com/team/mike-ryan/ 2025-12-06T10:33:35+00:00 https://eliquent.com/team/steven-bowen-ph-d/ 2025-12-05T15:52:41+00:00 https://eliquent.com/team/silvana-borges/ 2025-12-05T15:53:21+00:00 https://eliquent.com/team/julia-carrier-phd/ 2025-12-05T15:13:13+00:00 https://eliquent.com/team/grace-e-mcnally/ 2025-12-05T15:44:35+00:00 https://eliquent.com/team/lacey-lucree/ 2025-12-05T17:51:41+00:00 https://eliquent.com/team/maya-davis/ 2025-12-06T10:20:23+00:00 https://eliquent.com/team/kristen-grumet-2/ 2026-01-13T13:59:51+00:00 https://eliquent.com/team/meredith-francis/ 2025-12-06T10:33:14+00:00 https://eliquent.com/team/saurabh-khurana/ 2025-12-05T17:52:09+00:00 https://eliquent.com/team/kathleen-retterson-2/ 2026-01-13T14:00:36+00:00 https://eliquent.com/team/brooke-k-higgins/ 2025-12-06T10:39:03+00:00 https://eliquent.com/team/shannon-chesterfield/ 2026-01-13T13:55:16+00:00 https://eliquent.com/team/elizabeth-oestreich-2/ 2026-01-13T14:13:46+00:00 https://eliquent.com/team/shaun-stapleton/ 2025-12-05T15:12:05+00:00 https://eliquent.com/team/mcgarry/ 2025-12-05T15:53:36+00:00 https://eliquent.com/team/thomas-r-berry-pharm-d/ 2025-12-05T15:43:07+00:00 https://eliquent.com/team/brijesh-patel/ 2025-12-06T10:21:29+00:00 https://eliquent.com/team/brian-burns-2/ 2026-01-15T20:31:04+00:00 https://eliquent.com/team/michael-edwards/ 2025-12-05T15:54:05+00:00 https://eliquent.com/team/erin-hartmann/ 2026-01-13T14:09:42+00:00 https://eliquent.com/team/rosa-qian/ 2025-12-05T17:51:19+00:00 https://eliquent.com/team/joe-jimenez/ 2025-12-06T11:02:53+00:00 https://eliquent.com/team/michael-ruck/ 2025-12-06T11:03:24+00:00 https://eliquent.com/team/kimberly-mccoy-mba-rac/ 2025-12-05T14:43:17+00:00 https://eliquent.com/team/emily-hess/ 2025-12-06T10:21:20+00:00 https://eliquent.com/team/mikio-ishizawa-2/ 2025-12-05T15:13:26+00:00 https://eliquent.com/team/ishan-samaddar/ 2026-01-13T14:05:46+00:00 https://eliquent.com/team/emma-jane-brookes/ 2025-12-06T10:19:29+00:00 https://eliquent.com/team/michael-spence/ 2025-12-06T10:54:46+00:00 https://eliquent.com/team/robin-huff/ 2025-12-05T17:48:31+00:00 https://eliquent.com/team/dan-zenker/ 2025-12-06T10:19:38+00:00 https://eliquent.com/team/douglas-hill/ 2025-12-06T10:19:08+00:00 https://eliquent.com/team/ray-woll/ 2025-12-06T11:04:37+00:00 https://eliquent.com/team/abhishek-kumar/ 2025-12-06T10:19:18+00:00 https://eliquent.com/team/vince-pace/ 2025-12-06T10:20:01+00:00 https://eliquent.com/team/indy-ahluwalia/ 2025-12-06T10:19:49+00:00 https://eliquent.com/team/tiffany-lucas/ 2026-03-26T10:00:44+00:00 https://eliquent.com/team/christopher-albert/ 2025-12-06T10:21:10+00:00 https://eliquent.com/team/naoya-kato/ 2025-12-05T15:40:19+00:00 https://eliquent.com/team/jose-zorrilla/ 2025-12-06T11:04:09+00:00 https://eliquent.com/team/whitney-sandberg/ 2025-12-06T11:03:53+00:00 https://eliquent.com/team/colleen-locicero/ 2025-12-06T10:43:39+00:00 https://eliquent.com/team/samantha-eakes-mph/ 2025-12-05T15:43:52+00:00 https://eliquent.com/team/ashleen-sappal/ 2025-12-05T14:46:07+00:00 https://eliquent.com/team/margery-ma-ph-d/ 2025-12-05T15:11:32+00:00 https://eliquent.com/team/vincent-hon-kin-li-ph-d/ 2025-12-05T15:40:35+00:00 https://eliquent.com/team/dawn-l-wydner/ 2025-12-05T14:16:51+00:00 https://eliquent.com/team/shinichi-nakano/ 2026-01-13T13:52:40+00:00 https://eliquent.com/team/bill-zhao-m-s-rac/ 2025-12-05T14:45:36+00:00 https://eliquent.com/team/carolyn-s-tomlinson/ 2026-01-13T09:33:11+00:00 https://eliquent.com/team/emma-william/ 2026-01-13T14:13:04+00:00 https://eliquent.com/team/ziyan-zhang-ph-d/ 2025-12-05T15:11:51+00:00 https://eliquent.com/team/masayoshi-takezawa/ 2025-12-05T15:10:49+00:00 https://eliquent.com/team/hitomi-shimizu/ 2025-12-05T14:44:52+00:00 https://eliquent.com/team/john-osullivan/ 2025-12-06T11:03:39+00:00 https://eliquent.com/team/rob-mcgowan/ 2025-12-06T11:02:06+00:00 https://eliquent.com/team/rieko-shimazu/ 2025-12-05T14:33:55+00:00 https://eliquent.com/team/rie-taguchi/ 2025-12-05T14:33:42+00:00 https://eliquent.com/team/chio-takahisa/ 2025-12-05T14:33:30+00:00 https://eliquent.com/team/hirofumi-murakoshi/ 2025-12-05T14:33:15+00:00 https://eliquent.com/team/gale-milller/ 2025-12-05T14:43:51+00:00 https://eliquent.com/team/kathryn-berumen/ 2025-12-05T15:54:19+00:00 https://eliquent.com/team/john-love-2/ 2026-01-13T14:01:35+00:00 https://eliquent.com/team/takao-yamazaki-ph-d/ 2025-12-05T14:32:43+00:00 https://eliquent.com/team/rika-saito/ 2025-12-05T14:30:37+00:00 https://eliquent.com/team/guangyuan-claire-li-ph-d-rac-drugs/ 2025-12-05T14:32:00+00:00 https://eliquent.com/team/teruyo-negoro/ 2025-12-05T14:31:18+00:00 https://eliquent.com/team/constantina-kinni/ 2026-01-13T14:16:29+00:00 https://eliquent.com/team/william-bill-ditty/ 2025-12-05T14:03:36+00:00 https://eliquent.com/team/deborah-hatcher/ 2025-12-05T14:27:21+00:00 https://eliquent.com/team/wendy-kinal/ 2025-12-05T14:32:27+00:00 https://eliquent.com/team/mengxi-sun-ph-d/ 2025-12-05T14:17:31+00:00 https://eliquent.com/team/elena-zachariades-ph-d/ 2025-12-05T14:16:38+00:00 https://eliquent.com/team/shakeeb-ur-rehman/ 2025-12-05T14:16:15+00:00 https://eliquent.com/team/colm-coveney/ 2025-12-06T10:53:28+00:00 https://eliquent.com/team/maryam-tahoor/ 2025-12-05T14:16:04+00:00 https://eliquent.com/team/ayesha-sultana/ 2025-12-05T14:06:19+00:00 https://eliquent.com/team/saziya-saiyed-mpharm/ 2025-12-05T14:06:05+00:00 https://eliquent.com/team/sarah-parkes/ 2025-12-05T14:05:52+00:00 https://eliquent.com/team/brian-odonovan/ 2025-12-06T10:54:14+00:00 https://eliquent.com/team/talhat-mahmood/ 2025-12-05T14:05:28+00:00 https://eliquent.com/team/fitzroy-dawkins/ 2025-12-05T17:52:51+00:00 https://eliquent.com/team/jose-cortes/ 2025-12-06T10:53:17+00:00 https://eliquent.com/team/ann-oconnor-bsc-pharm-mpsi/ 2025-12-06T11:09:29+00:00 https://eliquent.com/team/john-tritschler/ 2025-12-06T10:55:08+00:00 https://eliquent.com/team/jonathan-wong/ 2025-12-06T11:01:36+00:00 https://eliquent.com/team/yumiko-tsujimura/ 2025-12-05T14:17:44+00:00 https://eliquent.com/team/adrienne-vanschoonhoven/ 2025-12-06T10:55:18+00:00 https://eliquent.com/team/margaretta-sweezy/ 2025-12-06T10:54:56+00:00 https://eliquent.com/team/maninder-rattu/ 2025-12-05T17:50:21+00:00 https://eliquent.com/team/emiko-takezawa/ 2025-12-05T17:47:28+00:00 https://eliquent.com/team/ridwan-mebude/ 2025-12-05T15:56:09+00:00 https://eliquent.com/team/diana-skotsiou/ 2025-12-05T15:55:45+00:00 https://eliquent.com/team/lubna-rajiwate/ 2025-12-05T15:55:30+00:00 https://eliquent.com/team/joanna-paul-phd/ 2025-12-05T15:55:21+00:00 https://eliquent.com/team/william-tillett/ 2025-12-05T15:55:01+00:00 https://eliquent.com/team/david-telling/ 2025-12-06T11:09:45+00:00 https://eliquent.com/team/rohullah-latif/ 2025-12-06T10:31:47+00:00 https://eliquent.com/team/maulik-patel/ 2025-12-06T10:31:27+00:00 https://eliquent.com/team/rob-chapman-pmp-cssbb/ 2025-12-06T10:32:03+00:00 https://eliquent.com/team/djordje-djordjic-mpharm/ 2025-12-06T10:40:16+00:00 https://eliquent.com/team/jovana-ilkic-ph-d/ 2025-12-06T10:39:45+00:00 https://eliquent.com/team/natasa-tanasic/ 2025-12-06T10:39:26+00:00 https://eliquent.com/team/aleksandra-rosic/ 2025-12-06T10:33:58+00:00 https://eliquent.com/team/beulah-dadala/ 2025-12-06T10:33:48+00:00 https://eliquent.com/team/chun-chun-cheng-ph-d/ 2025-12-06T10:33:25+00:00 https://eliquent.com/team/jayita-chakraborty/ 2025-12-06T10:33:02+00:00 https://eliquent.com/team/dhruv-sharma-b-tech/ 2025-12-06T10:32:54+00:00 https://eliquent.com/team/arnaud-bertrand/ 2025-12-06T10:32:38+00:00 https://eliquent.com/team/angelina-gilbert-swann/ 2025-12-06T10:32:26+00:00 https://eliquent.com/team/pam-strowgger/ 2025-12-06T10:32:14+00:00 https://eliquent.com/team/michael-kazakevich/ 2025-12-06T10:30:58+00:00 https://eliquent.com/team/unmesh-chimalwar/ 2025-10-22T14:03:02+00:00 https://eliquent.com/team/kurt-moerck/ 2025-10-30T17:18:18+00:00 https://eliquent.com/team/brice-dreamer-mba/ 2025-10-30T20:16:06+00:00 https://eliquent.com/team/zain-saleem/ 2025-12-06T11:10:29+00:00 https://eliquent.com/team/pekka-lukkari-ph-d-m-sc/ 2025-12-06T11:10:15+00:00 https://eliquent.com/team/shonoi-ming-ph-d/ 2025-11-03T09:16:10+00:00 https://eliquent.com/team/daniel-kavanagh/ 2026-01-13T14:15:58+00:00 https://eliquent.com/team/emily-anne-alvarez/ 2025-12-06T11:01:50+00:00 https://eliquent.com/team/nakkia-s-gray/ 2025-12-05T14:19:05+00:00 https://eliquent.com/team/israel-bacon/ 2025-12-05T14:17:55+00:00 https://eliquent.com/team/emily-warner/ 2025-12-06T10:55:27+00:00 https://eliquent.com/team/mara-mitchell/ 2025-08-08T19:56:50+00:00 https://eliquent.com/team/ann-hale/ 2025-12-05T14:04:57+00:00 https://eliquent.com/team/catherine-rowe/ 2025-12-05T14:44:40+00:00 https://eliquent.com/team/heidi-hudson/ 2025-12-05T14:31:34+00:00 https://eliquent.com/team/brittany-milby/ 2025-12-05T14:43:35+00:00 https://eliquent.com/team/krystal-nelson/ 2025-12-05T14:17:18+00:00 https://eliquent.com/team/jian-lu/ 2025-12-05T14:17:03+00:00 https://eliquent.com/team/emanuela-de-santis/ 2025-12-06T10:54:02+00:00 https://eliquent.com/team/hannah-withnell/ 2025-12-05T14:16:23+00:00 https://eliquent.com/team/patrice-mistretta/ 2025-12-06T10:54:37+00:00 https://eliquent.com/team/colin-larsen/ 2025-12-06T10:51:42+00:00 https://eliquent.com/team/elleigh-morris/ 2025-12-05T14:44:05+00:00 https://eliquent.com/team/laura-c-bartee/ 2025-12-05T14:18:09+00:00 https://eliquent.com/team/yasue-ishida-mba/ 2025-12-05T14:04:25+00:00 https://eliquent.com/team/lyndsey-n-beasley-cpa/ 2025-12-05T14:18:20+00:00 https://eliquent.com/team/george-hong/ 2025-12-06T10:51:29+00:00 https://eliquent.com/team/nicki-benson/ 2025-12-05T14:04:04+00:00 https://eliquent.com/team/ashley-alleway/ 2025-12-05T14:07:05+00:00 https://eliquent.com/team/yogindra-dellow/ 2025-11-03T13:16:36+00:00 https://eliquent.com/team/sus-dunne/ 2025-12-05T14:04:44+00:00 https://eliquent.com/team/takeo-sugawara/ 2025-12-16T15:25:49+00:00 https://eliquent.com/team/tracy-obrien/ 2025-12-05T17:52:17+00:00 https://eliquent.com/team/ziqi-zhang/ 2025-12-05T17:49:28+00:00 https://eliquent.com/team/laura-west/ 2025-12-06T11:04:23+00:00 https://eliquent.com/team/shenggang-wang/ 2025-12-05T17:48:56+00:00 https://eliquent.com/team/mariceles-mendoza/ 2025-12-06T10:20:37+00:00 https://eliquent.com/team/neelimarani-tiyyagura/ 2025-12-05T17:48:40+00:00 https://eliquent.com/team/yohei-nishizato/ 2025-12-05T17:48:18+00:00 https://eliquent.com/team/andrew-trippi/ 2025-12-06T10:20:59+00:00 https://eliquent.com/team/eliza-burton-deriso/ 2025-12-06T10:38:49+00:00